Ankyrin Repeat Domain 1, Ankrd1, A Novel Determinant Of Cisplatin Sensitivity Expressed In Ovarian Cancer

seen on clincancerres.aacrjournals.org


G Medeot Designer, Ankyrin Repeat Domain 1, Ankrd1, A Novel Determinant Of Cisplatin Sensitivity Expressed In Ovarian Cancer G Medeot Designer

Purpose: The standard of care for ovarian cancer includes platinum-based chemotherapy.

It is not possible, however, to predict clinical platinum sensitivity or to design rational strategies to overcome resistance. We used a novel approach to identify altered gene expression associated with high sensitivity to cisplatin, to define novel targets to sensitize tumor cells to platins and ultimately improve the effectiveness of this widely used class of chemotherapeutics. Experimental Design: Using differential display PCR, we identified genes differentially expressed in a mutagenized cell line with unusual sensitivity to cisplatin.

The most highly differentially expressed gene was selected, and its role in determining cisplatin sensitivity was validated by gene transfection and small interfering RNA (siRNA) approaches, by association of expression levels with cisplatin sensitivity in cell lines, and by association of tumor expression levels with survival in a retrospective cohort of 71 patients with serous ovarian adenocarcinoma. Results: The most highly differently expressed gene identified was ANKRD1, ankyrin repeat domain 1 (cardiac muscle). ANKRD1 mRNA levels were correlated with platinum sensitivity in cell lines, and most significantly, decreasing ANKRD1 using siRNA increased cisplatin sensitivity >2-fold.

Also find the other picture or article about G Medeot Designer We hope it can help you to get information of the picture


Tagged with

Find Interior Design product